The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Since the publication of the Q5A(R1) Guideline in 1999, there has been advances in biotechnology product development and manufacturing that are not reflected in the original guideline…
ICH Q13, Continuous Manufacturing of Drug Substances and Drug Products, is progressing through document development with endorsement of Stage 1 expected in May 2021…